Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tissue physical adhesion refers to the process by which two or more tissues become physically connected, either through normal biological mechanisms like ECM sharing and cell-cell adhesion, or pathologically as fibrous adhesions post-injury/surgery/infection. While transient adhesions are crucial for wound healing and development, persistent pathological adhesions can cause pain, obstruction, and organ dysfunction. Key molecular components include ECM proteins (e.g., collagen, fibronectin), cell surface molecules (e.g., cadherins), and matrix enzymes involved in fibrinolysis.
Varied depending on specific approach. Anti-inflammatories reduce inflammation driving adhesion formation. Anti-adhesion barriers physically separate tissues during healing. Fibrinolytic agents degrade fibrin.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tissue Physical Adhesion.